BRINTIX Trademark

Trademark Overview

On Tuesday, April 22, 2014, a trademark application was filed for BRINTIX with the United States Patent and Trademark Office. The USPTO has given the BRINTIX trademark a serial number of 86259609. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 26, 2018. This trademark is owned by H. Lundbeck A/S. The BRINTIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyries, stroke, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes
brintix

General Information

Serial Number86259609
Word MarkBRINTIX
Filing DateTuesday, April 22, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 25, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyries, stroke, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes
Translation of Words in MarkThe wording "BRINTIX" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 6, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address2500 Valby 2500
DK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCopenhagen, Valby DK-2500
DK

Trademark Events

Event DateEvent Description
Monday, February 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, August 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2017EXTENSION 5 GRANTED
Tuesday, July 18, 2017EXTENSION 5 FILED
Tuesday, July 18, 2017TEAS EXTENSION RECEIVED
Tuesday, July 18, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2016EXTENSION 4 GRANTED
Wednesday, December 28, 2016EXTENSION 4 FILED
Wednesday, December 28, 2016TEAS EXTENSION RECEIVED
Tuesday, June 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2016EXTENSION 3 GRANTED
Thursday, June 2, 2016EXTENSION 3 FILED
Thursday, June 2, 2016TEAS EXTENSION RECEIVED
Wednesday, February 10, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2016EXTENSION 2 GRANTED
Monday, December 28, 2015EXTENSION 2 FILED
Sunday, February 7, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 28, 2015TEAS EXTENSION RECEIVED
Wednesday, June 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 16, 2015EXTENSION 1 GRANTED
Tuesday, May 19, 2015EXTENSION 1 FILED
Tuesday, June 16, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 19, 2015TEAS EXTENSION RECEIVED
Tuesday, January 20, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 25, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 25, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 5, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 23, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 6, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 6, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 29, 2014ASSIGNED TO LIE
Friday, September 26, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 2, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 2, 2014NON-FINAL ACTION E-MAILED
Saturday, August 2, 2014NON-FINAL ACTION WRITTEN
Friday, August 1, 2014ASSIGNED TO EXAMINER
Thursday, June 12, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 12, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 6, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 25, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

brintix substances pharmaceutical preparations system central treatment prevention nervous disease disorder